Mark Hochstetler

Mark Hochstetler possesses extensive experience in business development and strategic planning, currently serving at Codexis, Inc. since January 2022. Previous roles include positions at Adamas Pharmaceuticals, Inc., and ConcertAI, with specific focus on corporate development and business development. Notable leadership experience includes serving as Sr. Director of Business Development at PaxVax, Inc., and Director at Decision Resources Group. Mark also held a CFO position at OPK Biotech, LLC, and worked as a consultant for Leerink Swann Strategic Advisors. An academic background includes an MBA in Health Sector Management from Duke University's Fuqua School of Business and a BA in Political Science from Stanford University.